Bilaketaren emaitzak - Michal Mark‐Danieli

  • Erakusten 1 - 2 emaitzak -- 2
Findu emaitzak
  1. 1
    Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target

    Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target nork Naomi Pode‐Shakked, Orit Harari‐Steinberg, Y. Haberman-Ziv, Eithan Rom‐Gross, S Bahar, Dashne Shamall Omer, Sally Metsuyanim, Ella Buzhor, Jasmin Jacob–Hirsch, Ronald S. Goldstein, Michal Mark‐Danieli, Benjamin Dekel

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

    The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets nork Naomi Pode‐Shakked, Rachel Shukrun, Michal Mark‐Danieli, Peter Tsvetkov, Sarit Bahar, Sara Pri‐Chen, Ronald S. Goldstein, Eithan Rom‐Gross, Yoram Mor, Eddie Fridman, Karen Meir, Amos J. Simon, Marcus J. Magister, Naftali Kaminski, Victor S. Goldmacher, Orit Harari‐Steinberg, Benjamin Dekel

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: